News

Essilor Alive Summit Recap

On Friday, March 3, 2017, Varilux Xperience Partners gathered in Vancouver, British Columbia, for the Alive Summit.

Read More

Carl Zeiss Meditec Raises €317 Million for Acquisitions

Carl Zeiss Meditec AG reported Tuesday that it has issued 8,130,960 new shares, a ten percent increase in share capital, in order to raise cash for acquisitions.

Read More

“Myopia Cell” Discovered

Researchers at Northwestern Medicine have discovered a cell responsible for controlling the growth and development of the eye in childhood.

Read More

Dragon Eyewear for the Sporty Individual

Dragon Eyewear introduces the Detail Collection for the active adventurer in all of us. Dr. Reflector (photo), Dr. Method, and Dr. Channel are three modern sporty sunglasses designed for fun, sport and function.

Read More

Timeless, Elegance, Functionality. Tokado

Tokado is an exquisite frame collection designed in Canada and manufactured in Italy. Optiman introduces this very European feeling spring frame launch encompassing a retro flair.

Read More

Acquisitions Spur Record Growth at New Look

Group Reports nearly $200 million revenue in 2016 year end reports.

Read More

Safilo Group 2016 Financial Results

The Board of Directors of Safilo Group S.p.A. approved the financial statement for the year ended 31 December 2016.

Read More

Safilo Unveils the SAFILO Eyewear Collection Launching Autumn 2017

Redesigned with a new concept and positioning, the new SAFILO collection renews its long standing heritage of technical and aesthetic content, with a new optical frames full range celebrating the superior design, functional innovation and “Made-in-Italy” know-how.

Read More

Organic Retinal Prosthesis Restores Vision in Rats

Scientists at the Italian Institute of Technology have developed a prosthesis that can be implanted into the eye to serve as a substitute for the damaged retina.

Read More

Drug Delivery Through Contact Lenses

Advances in nanotechnology and lens materials means contact lenses capable of controlled delivery drugs to the eye could be just around the corner, and could represent a breakthrough in the treatment of glaucoma, myopia and other eye diseases.

Read More